A Value Manager’s Take On Disruption: Advancements In Precision Medicine – Causeway Capital

Share:

Contact Us

Contact us to learn more about our insights

‪

* Required information

First Name *

Last Name *

Email *

Phone Number

Company *

Country

Investor Type

Strategy of Interest

Comments/Questions

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

‬

The emerging practice of precision medicine, the use of genetic or other biomarker information to tailor treatments, has already led to life-changing healthcare breakthroughs for patients fighting cancer and other diseases. The research is advancing rapidly and the prospects of further improving patient outcomes is exciting. How is precision medicine evolving and what are the implications for investors?

In the fifth installment of the Causeway Disruption Series, Fundamental Portfolio Manager Alessandro Valentini will review the past, present and future of precision medicine and discuss some of the investment opportunities we are uncovering in this area.

Download PDF

See more Region / Sector Specific insights

Terms and Conditions of Use:

Please read the following before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which Causeway Funds plc is authorised for sale.

Causeway Funds plc (the "Fund") is authorised by the Central Bank of Ireland as an Undertaking for Collective Investment in Transferable Securities pursuant to the European Communities (Undertaking for Collective Investment in Transferable Securities) Regulations 2011 (S.I. 352 of 2011) of Ireland, as amended.

The Fund and its sub-funds are only authorised in certain jurisdictions.

This website is not aimed at any US person (as defined by Regulations S of the US Securities Act of 1933) and is not for distribution and does not constitute an offer to or solicitation to buy any securities in the United States. Purchase orders from US investors or other ineligible investors will not be accepted. This site is not intended for US persons. If you are trying to find information about the Causeway Funds registered for sale in the United States, please go to our Funds page . Restrictions may also apply to residents of other countries.

Subscriptions will only be received and shares issued on the basis of the current prospectus for the Fund and relevant supplement for a sub-fund. It is your responsibility to use such prospectus and supplement, and by making an application you will be deemed to represent that you have read such prospectus and supplement and agree to be bound by its contents. Copies of the prospectus, supplements and, when available, other reports can be obtained from this website. The Fund prices contained in this website are indicative only and should not be relied upon for dealing. No warranty or representation is made with respect to the information contained in this website, including, without limitation, that the information is accurate, complete or timely. None of the information, whether in part or full, should be copied, reproduced or redistributed in any form. Past performance is not indicative of future results.

The information on this website is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security that may be referenced on or through this website. Unless otherwise specified, it is not intended to be directed to any person(s) in particular. Information from this website must not be used in any jurisdiction where prohibited by law and must not be used in a way that would be contrary to local law or legislation. You should not access this site or information on this site if you know that your access would contravene applicable local, national or international laws. No investment advice, tax advice, or legal advice is provided through this website, and you agree that this website will not be used by you for these purposes. No representation is given that shares, products, or services identified on, or accessible through, this website are suitable for any particular investor.

By clicking the box below, you confirm and represent that you are from an eligible jurisdiction to review material relating to the Fund, or that you are authorised to conduct investment business in the jurisdiction within which you are resident and, under the law of that jurisdiction, you are authorised to view material relating to collective investment schemes). It is critical that the information you provide is accurate and a failure to provide accurate information will be a material breach of these terms and conditions.

I am a resident of Ireland or the United Kingdom.

I am an investor in Causeway Funds plc or a prospective investor who has received a Fund Application from Causeway Funds plc.

I am resident in Italy and a professional investor (“investitore professionale”), as defined by articles 1, paragraph 1, letter m-undecies and 6, paragraphs 2-quinquies and 2-sexies of the Italian Consolidated Text of the rules on financial intermediation – Legislative Decree no. 58 of February 24, 1998, as amended - (the “TUF”), and by the second level regulations of CONSOB for the implementation of the TUF, namely Annex 3 to CONSOB Regulation no 16190 of October 29, 2007 on Intermediaries, implementing the definitions of “professional client” under the Markets in Financial Instruments Directive (“MiFID”).

If you are a resident of any other country please view our strategies.